Literature DB >> 13655401

Treatment of Peyronie's disease with potassium para-aminobenzoate (potaba).

C J ZARAFONETIS, T M HORRAX.   

Abstract

Entities:  

Keywords:  PARA-AMINOBENZOIC ACID/therapeutic use; PENIS/diseases

Mesh:

Substances:

Year:  1959        PMID: 13655401     DOI: 10.1016/s0022-5347(17)66108-1

Source DB:  PubMed          Journal:  J Urol        ISSN: 0022-5347            Impact factor:   7.450


× No keyword cloud information.
  15 in total

1.  PEYRONIE'S DISEASE: A REVIEW OF ETIOLOGY, DIAGNOSIS, AND MANAGEMENT.

Authors:  Aylin N Bilgutay; Alexander W Pastuszak
Journal:  Curr Sex Health Rep       Date:  2015-06-01

Review 2.  Treatment of Peyronie's disease: 2012 update.

Authors:  Ege Can Serefoglu; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2011-12       Impact factor: 3.092

Review 3.  Contemporary Review of Peyronie's Disease Treatment.

Authors:  Edward Capoccia; Laurence A Levine
Journal:  Curr Urol Rep       Date:  2018-05-17       Impact factor: 3.092

Review 4.  Update on medical management of Peyronie's disease.

Authors:  Ronny B W Tan; Premsant Sangkum; Gregory C Mitchell; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2014-06       Impact factor: 3.092

Review 5.  Conservative Therapy for Peyronie's Disease: a Contemporary Review of the Literature.

Authors:  Ayad Yousif; Caleb Natale; Wayne J G Hellstrom
Journal:  Curr Urol Rep       Date:  2021-01-08       Impact factor: 3.092

6.  Six months in South Africa.

Authors:  A Savage
Journal:  Br Med J       Date:  1978-07-29

Review 7.  Pharmacological Management of Peyronie's Disease.

Authors:  Landon W Trost; Serap Gur; Wayne J G Hellstrom
Journal:  Drugs       Date:  2007       Impact factor: 9.546

8.  Effect of intralesional verapamil for treatment of Peyronie's disease: a randomized single-blind, placebo-controlled study.

Authors:  M Shirazi; A R Haghpanah; M Badiee; M A Afrasiabi; S Haghpanah
Journal:  Int Urol Nephrol       Date:  2009-02-06       Impact factor: 2.370

9.  Current and emerging treatment options for Peyronie's disease.

Authors:  Ahmet Gokce; Julie C Wang; Mary K Powers; Wayne Jg Hellstrom
Journal:  Res Rep Urol       Date:  2013-01-14

Review 10.  Role of collagenase clostridium histolyticum in Peyronie's disease.

Authors:  Taylor C Peak; Gregory C Mitchell; Faysal A Yafi; Wayne J Hellstrom
Journal:  Biologics       Date:  2015-09-29
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.